Mireia Diaz
Biographic Data
| ID | 3893063 |
|---|---|
| NAME | Mireia Diaz |
| GIVEN NAMES | Mireia |
| FAMILY NAME | Diaz |
| SIGNATURE | DÍAZ M |
| AFFILIATIONS | Universitat Autonòma de Barcelona |
| ORCID | 0000-0001-9360-4548 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2008 |
| LATEST PUBLICATION YEAR | 2017 |
| H-INDEX | 0 |
Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: The CRIVERVA study
ClinicalTrials.gov Identifier: NCT01373723
Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: Policy Implications
Approximately 70% of cases of cervical cancer worldwide are caused by genotypes 16 and 18 of human papillomavirus (HPV), which is sexually transmitted. With the availability of an effective vaccine against these HPV types, there is real hope for reducing the global burden of cervical cancer in developing countries. Stakeholders faced with decisions about where to invest money to improve health must consider the burden of disease caused by cervica…
No prominent works on this page.
Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: Policy Implications
Approximately 70% of cases of cervical cancer worldwide are caused by genotypes 16 and 18 of human papillomavirus (HPV), which is sexually transmitted. With the availability of an effective vaccine against these HPV types, there is real hope for reducing the global burden of cervical cancer in developing countries. Stakeholders faced with decisions about where to invest money to improve health must consider the burden of disease caused by cervica…
Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: The CRIVERVA study
ClinicalTrials.gov Identifier: NCT01373723
Cancer (2 works) · Cervical cancer (2 works) · Cervical Cancer and HPV Research (2 works) · Cost effectiveness (2 works) · Medicine (2 works) · Biostatistics (1 works) · Business (1 works) · Cervical screening (1 works) · Clinical practice guidelines implementation (1 works) · Confidence interval (1 works)